Onos Health Raises $17 Million for Behavioral Health AI Platform

Aug 26, 2026
Onos Health raised $17 million in Series A funding led by Costanoa Ventures, with participation from Flare Capital Partners and CVS Health Ventures. The company provides an AI platform for behavioral health clinical intelligence used by health plans.

Onos Health has raised $17 million in Series A funding led by Costanoa Ventures, with participation from Flare Capital Partners and strategic investment from CVS Health Ventures, the company announced in a press release. The company said the financing follows commercial momentum with U.S. health plans, including Aetna, using its platform.

Onos Health provides a behavioral health clinical intelligence platform for payers. Its AI platform combines claims, utilization data, clinical documentation, and quality guidelines to show care pathways across member populations.

The platform analyzes structured and unstructured data to identify care patterns, treatment gaps, and areas for quality improvement. Onos plans to use the funding to accelerate adoption of the platform by health plans.

We hope you enjoyed this article

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.